NCT07527143RecruitingAccepts Healthy Volunteers
Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
Mayo Clinic
Start Date
6/10/2026
Completion Date
6/10/2027
Summary
This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
Eligibility Criteria
Age Range: 45 years to No maximum
Inclusion Criteria:
* Self-identified Black individuals ≥ 45 years with an intact uterus
* Assigned female sex at birth
* Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause)
* Willing to participate in a 45-minute virtual interview
Exclusion Criteria:
* Previous or current diagnosis of endometrial cancer
Interventions
OTHER
Non-Interventional Study
Conditions
Endometrial Carcinoma
Locations
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United States